Sign in

CIK 0001326732 · Accelerated filer

Ticker
XNCR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
201622502
Phone
626-305-5900
Business address
465 N. HALSTEAD ST., SUITE 200, PASADENA, CA, 91107
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,591,617
in 2 filings

Net −$3,591,617. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-06-12 SIMPSON TODD E Director Grant or award · Stock Option (Right to Buy) +27,372 27,372
2025-06-12 RANIERI RICHARD J Director Grant or award 10b5-1 +13,686 22,176
2025-06-12 RANIERI RICHARD J Director Grant or award · Stock Option (Right to Buy) 10b5-1 +27,372 27,372
2025-05-02 Valente Nancy EVP, Chief Development Officer Sale −4,616 $11.03 $51K 49,169
2025-04-10 Cornelissen Bart Jan SR. VICE PRESIDENT & CFO Sale −3,750 $8.06 $30K 61,348
2025-03-13 SIMPSON TODD E Director Grant or award · Stock Option (Right to Buy) +43,337 43,337
2025-03-10 Valente Nancy EVP, Chief Development Officer Sale −2,565 $13.60 $35K 53,785
2025-03-10 Eckert Celia SVP, GENERAL COUNSEL Sale −5,740 $13.60 $78K 63,507
2025-03-10 Desjarlais John R SR. VICE PRESIDENT & CSO Sale −9,697 $13.60 $132K 236,574
2025-03-10 Dahiyat Bassil I PRESIDENT & CEO Sale −19,716 $13.60 $268K 465,419
2025-03-04 Desjarlais John R SR. VICE PRESIDENT & CSO Grant or award +29,851 246,271
2025-03-04 Desjarlais John R SR. VICE PRESIDENT & CSO Grant or award · Stock Option (Right to Buy) +89,552 89,552
2025-03-04 Eckert Celia SVP, GENERAL COUNSEL Grant or award +21,949 69,247
2025-03-04 Eckert Celia SVP, GENERAL COUNSEL Grant or award · Stock Option (Right to Buy) +65,847 65,847
2025-03-04 Dahiyat Bassil I PRESIDENT & CEO Grant or award +109,745 485,135
2025-03-04 Dahiyat Bassil I PRESIDENT & CEO Grant or award · Stock Option (Right to Buy) +329,236 329,236
2025-03-04 Cornelissen Bart Jan SR. VICE PRESIDENT & CFO Grant or award +21,949 65,098
2025-03-04 Cornelissen Bart Jan SR. VICE PRESIDENT & CFO Grant or award · Stock Option (Right to Buy) +65,847 65,847
2025-02-03 Desjarlais John R SR. VICE PRESIDENT & CSO Option exercise +3,542 $15.69 $56K 216,420
2025-02-03 Desjarlais John R SR. VICE PRESIDENT & CSO Option exercise · Stock Option (Right to Buy) −3,542 0

Page 5 of 11 · 211 trades